Association Between Bitter Taste Receptor Phenotype and Clinical Outcomes Among Patients With COVID-19

Abstract

IMPORTANCE Bitter taste receptors (T2Rs) have been implicated in sinonasal innate immunity, and genetic variation conferred by allelic variants in T2R genes is associated with variation in upper respiratory tract pathogen susceptibility, symptoms, and outcomes. Bitter taste receptor phenotype appears to be associated with the clinical course and symptom duration of SARS-CoV-2 infection.OBJECTIVE To evaluate the association between T2R phenotype and patient clinical course after infection with SARS-CoV-2. DESIGN, SETTING, AND PARTICIPANTSA prospective cohort study was performed from July 1 through September 30, 2020, at a tertiary outpatient clinical practice and inpatient hospital in the United States among 1935 participants (patients and health care workers) with occupational exposure to SARS-CoV-2. EXPOSURE Exposure to SARS-CoV-2. MAIN OUTCOMES AND MEASURES Participants underwent T2R38 phenotype taste testing to determine whether they were supertasters (those who experienced greater intensity of bitter tastes), tasters, or nontasters (those who experienced low intensity of bitter tastes or no bitter tastes) and underwent evaluation for lack of infection with SARS-CoV-2 via polymerase chain reaction (PCR) testing and IgM and IgG testing. A group of participants was randomly selected for genotype analysis to correlate phenotype. Participants were followed up until confirmation of infection with SARS-CoV-2 via PCR testing. Phenotype of T2R38 was retested after infection with SARS-CoV-2. The results were compared with clinical course. RESULTS A total of 1935 individuals (1101 women [56.9%]; mean [SD] age, 45.5 [13.9] years) participated in the study. Results of phenotype taste testing showed that 508 (26.3%) were supertasters, 917 (47.4%) were tasters, and 510 (26.4%) were nontasters. A total of 266 participants (13.7%) had positive PCR test results for SARS-CoV-2. Of these, 55 (20.7%) required hospitalization.Symptom duration among patients with positive results ranged from 0 to 48 days. Nontasters were significantly more likely than tasters and supertasters to test positive for SARS-CoV-2 (odds ratio, 10.1 [95% CI, 5.8-17.8]; P < .001), to be hospitalized once infected (odds ratio, 3.9 [1.5-10.2]; P = .006), and to be symptomatic for a longer duration (mean [SE] duration, 23.7 [0.5] days vs 13.5 [0.4] days vs 5.0 [0.6] days; P < .001). A total of 47 of 55 patients (85.5%) with COVID-19 who required inpatient admission were nontasters. Conversely, 15 of 266 patients (5.6%) with positive PCR test results were supertasters.CONCLUSIONS AND RELEVANCE This cohort study suggests that T2R38 receptor allelic variants were associated with participants' innate immune response toward SARS-CoV-2. The T2R phenotype was associated with patients' clinical course after SARS-CoV-2 infection. Nontasters were more likely (continued) Key Points Question What is the association between the bitter taste receptor phenotype and outcomes after infection with SARS-CoV-2? Findings In this cohort study of 1935 adults, 266 tested positive for...

The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature

“… ( Grimaudo et al, 2021 ) TAS2R38 Not mentioned USA 1935, 265 tested positive T2Rs may protect against illness by SARS-CoV-2. ( Barham et al, 2021 ) DDR1 rs17047200 Egypt 141 patients, 100 controls The AG genotype of the DDR1 rs4618569is associated with poor outcomes in COVID-19 patients. ( Agwa et al, 2021 ) TLR3 rs3775291 Spain and Italy N/A A missense mutation in TLR3 (rs3775291) is associated with severe disease.…”

Maternal and Neonatal Outcomes Associated with Mild COVID-19 Infection in an Obstetric Cohort in Brazil

“…These discrepancies may be a result of different SARS-CoV-2 variants or differences in the genetic background of the population, as phenotypic expression of bitter taste receptors appeared to be associated with symptoms, immune response, clinical course, and recovery from COVID-19 infection. 33 Several studies in different countries have shown the long-term impact of COVID-19 on an individual's health. 34 Some research reported persistent symptoms extending beyond the period of initial illness or hospitalization.…”

“…These discrepancies may be a result of different SARS-CoV-2 variants or differences in the genetic background of the population, as phenotypic expression of bitter taste receptors appeared to be associated with symptoms, immune response, clinical course, and recovery from COVID-19 infection. 33 …”

Deep learning identified genetic variants associated with COVID-19 related mortality

“…This intronless taste receptor gene encodes a 7-transmembrane receptor protein, functioning as a bitter taste receptor [34]. Studies have shown that individuals who reported experiencing weak or no bitter tastes were considerably more likely to test positive for COVID-19, to be hospitalized, and to be symptomatic for a longer duration [35]. In addition, recent studies have been conducted that reduced TAS2R expression may influence the response to Chloroquine.…”